Patient Focus
March 12, 2021
Decades of Pain and Uncertainty: Donna’s AHP Story
For more than 20 years, Donna navigated debilitating pain, mysterious symptoms and uncertainty about her health. Today, with a better handle on her wellbeing...
Read More ›
March 2, 2021
When Are Kidney Stones a Red Flag?
According to some estimates, every 1 in 10 adults in the U.S. experiences a kidney stone, suggesting that kidney stones can be rather prevalent. But when are...
Read More ›
February 23, 2021
Rare Disease Day 2021: Rare Is Many. Rare Is Strong. Rare Is Proud.
While some aspects of living with a rare disease are similar, there is no singular shared experience. There is, however, a common sentiment among those...
Read More ›
December 7, 2020
Alnylam Releases 2nd Annual Patient Access Philosophy Report
The 2020 Alnylam Patient Access Philosophy Report details Alnylam's progress against key metrics related to patient access to its innovative RNAi therapeutics.
Read More ›
September 14, 2020
Navigating AHP and Pain During a Pandemic
As the COVID-19 pandemic continues to have a significant impact on people and communities around the world, it poses unique challenges for people living with...
Read More ›
August 3, 2020
How to Evaluate a Medicine for the Treatment of an Ultra-rare Disease Such as PH1
For a new medicine to become available, it needs to undergo stringent testing in clinical trials to evaluate its safety and, importantly, its efficacy...
Read More ›
June 2, 2020
Announcing the 2019-2020 Advocacy for Impact Grant Recipients
The Alnylam 2019-2020 Advocacy for Impact grant recipients come from five countries across three continents, and will receive grants totaling USD $270,000.00...
Read More ›
May 6, 2020
Navigating the Winding Road to Drug Approvals
Learn about the winding road and key members involved in getting a new drug approved.
Read More ›
March 30, 2020
Alnylam's Response to COVID-19
Learn more about Alnylam's response to the COVID-19 pandemic.
Read More ›
February 25, 2020
Advocacy for Impact Grants: Updates from the Field
Learn about how patient organizations who received 2018-2019 Alnylam Advocacy for Impact Grants have been putting those funds to work.
Read More ›
